This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 20 Mar 2019  |  North America  |  Mega Trends

    Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

    Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

    Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

    $4,950.00
  2. 20 Mar 2019  |  North America  |  Market Research

    2019 Predictions of the Global Life Sciences Industry

    As Novel Technologies Find Traction, Industry Focus Will Shift Towards Successful Monetization to Deliver Value-based Care

    he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...

    $1,500.00
  3. 11 Mar 2019  |  North America  |  Market Research

    Global Cell Therapy Market—Companies to Action, 2018

    A Collaborative Business Model With Focus on Stem Cells, Chimeric Antigen Receptor T (CAR-T) Cells and Combination Therapies Will Propel Market Growth

    The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...

    $3,000.00
  4. 07 Mar 2019  |  North America  |  Market Research

    Mergers and Acquisitions in the Global Life Sciences Industry, 2018

    M&As for Growth in Patient Engagement, Artificial Intelligence and Big Data Analytics are Driving Greater Vertical Integration

    The Healthcare industry has witnessed some of the largest mega-mergers in 2018 – mergers on the provider as well as the payer ends. While this has the potential to bring a shift in power centers in the ecosystem, each stakeholder has relied heavily on inorganic growth to maintain their stronghold. This Mergers and Acquisitions in Life Sciences In...

    $3,000.00
  5. 11 Feb 2019  |  North America  |  Market Research

    Global Laboratory Products Purchasing Trends, 2018–2019

    An End-user Perspective on Laboratory Spending Reveals Modest 2019 Budget Increases Following Healthier 2018 Spending

    Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2018 that centered around the state of their laboratories in 2018 and their expectations for 2019. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year...

    $1,500.00
  6. 14 Jan 2019  |  North America  |  Mega Trends

    Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023

    Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth

    Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...

    $4,950.00
  7. 29 Dec 2015  |  Global  |  Technology Research

    Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology

    Strategic Partnerships that are Transforming the Healthcare Industry

    In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...

    $4,950.00
  8. 24 Dec 2015  |  North America  |  Market Research

    Global Clinical Next-generation Sequencing Market

    Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement

    This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tab...

    $1,500.00
  9. 24 Dec 2015  |  Europe  |  Market Research

    Analysis of the Western European Clinical Laboratories Market

    Public Hospital Service Outsourcing to Drive the Growth of Independent Reference Labs

    Laboratory consolidations and outsourcing of services are providing more opportunities to the clinical labs. How the market is going to shape up and how the laboratory services structure is transforming in Western Europe is analyzed in this research service. The study provides market overview, market engineering measurements and revenue forecasts, ...

    $6,000.00
  10. 22 Dec 2015  |  Europe  |  Market Research

    Healthcare Services Market Outlook for Eastern Europe

    Country-level Analysis of Healthcare Systems and Private Hospital Markets

    This research service provides an overview of the healthcare systems of selected countries and a competitive analysis of their private hospital markets. The study includes data and analyses on each countrys economic, demographic, and epidemic conditions, the healthcare system and reforms, healthcare expenditure and fund flow system, healthcare infr...

    $4,950.00